Slebir John L 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Slebir John L
SVP General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2025-02-13+70,000→ 70,000 totalExercise: $12.69Exp: 2032-02-13→ Common Stock (70,000 underlying) - Exercise/Conversion
Common Stock
2025-02-13+14,000→ 28,397 total - Tax Payment
Common Stock
2025-02-13$12.69/sh−4,708$59,745→ 25,064 total - Exercise/Conversion
Restricted Stock Unit
2025-02-13−14,000→ 0 total→ Common Stock (14,000 underlying) - Award
Restricted Stock Unit
2025-02-13+14,000→ 14,000 total→ Common Stock (14,000 underlying) - Award
Restricted Stock Unit
2025-02-13+42,424→ 42,424 total→ Common Stock (42,424 underlying)
Footnotes (5)
- [F1]Each RSU represents a contingent right to receive one share of common stock. These RSUs vested upon the Issuer's achievement of a certain performance condition.
- [F2]Shares withheld by Dynavax Technologies Corporation to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]Includes 1,375 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 14, 2025.
- [F4]This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 13, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
- [F5]Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 13, 2025.